Bluejay Diagnostics, Inc. Increase (Decrease) in Other Operating Liabilities
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Other Operating Liabilities of $255.31 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2023-08-14
- Bluejay Diagnostics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was -$34.60K.
- Bluejay Diagnostics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $289.91K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|
| 2023-06-30 | -$34.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $255.31K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $289.91K 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $323.92K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |